Share on LinkedInShare on LinkedIn

ARTICLE · 27 JUNE 2023

Analogous References: The Same Field Or Problem Domain As The Invention

The US Court of Appeals for the Federal Circuit has overturned the Patent Trial & Appeal Board's determination of obviousness, stating that a prior art reference concerning automotive...

United StatesIntellectual Property

The US Court of Appeals for the Federal Circuit has overturned the Patent Trial & Appeal Board's determination of obviousness, stating that a prior art reference concerning automotive engine parts is not analogous to the challenged patent, which focused on injection devices designed for drug delivery. Sanofi-Aventis Deutschland GMBH v. Mylan Pharmaceuticals Inc., Case No. 21-1981 (Fed. Cir. May 9, 2023) (Reyna, Mayer, Cunningham, JJ.)

Sanofi-Aventis owns U.S. Patent No. RE47,614 ("the '614 patent"). The '614 patent pertains to a drug delivery device that can be customized to administer varying dosage quantities. Mylan petitioned the Board to institute IPR proceedings on the ground that the '614 patent is obvious based on a combination of three prior art references: Burren, Venezia, and de Gennes. Mylan relied on Burren, which was referenced in the '614 patent, to show implementation of springs within a drug-delivery device. Mylan combined Burren with Venezia to

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from